Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II

Recruiting now · Phase 1 · Has a placebo group

Conditions studied: Cannabis

In brief

The purpose of the study is to characterize the acute effects of cannabinoids in women relative to men and to begin probing the mechanisms that may underlie gender differences.

Key facts

Study ID

NCT04704271

Run by

Yale University

People needed

100

Starts

2019-10-09

Expected to finish

2027-12-01

Last updated by the study team

2026-04-29

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• At least one lifetime exposure to cannabis
• Good physical and mental health

You may not qualify if…

• Cannabis naïve individuals
• Major current or recent stressors

Where it is running

• Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine — West Haven, Connecticut, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.